Sign in

Trial site

MBAL Dr. Ivan Seliminski Sliven AD

Sliven, 8801, BulgariaEU-13 widening countryNot linked to an institution yet
  • 10running trials
  • 8closed trials

The trials here

What the 18 trials at this site are about, from their registry records.

Phase
  • Phase 312 trials
  • Phase 25 trials
  • Phase 11 trial
Status
  • Completed8 trials
  • Recruiting8 trials
  • Active, not recruiting1 trial
  • Not yet recruiting1 trial
Lead sponsor
  • Chiesi Farmaceutici S.p.A.3 trials
  • Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
  • Neurocrine Biosciences2 trials
  • Anthos Therapeutics, Inc.1 trial
  • Argenx1 trial
  • and 9 more

Running trials

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026

MBAL Dr. Ivan Seliminski Sliven AD: trial site – Frontlight Research